Regulatory News
Tuesday, August 9, 2016
LPC: Valeant loans rise after CEO says company to seek debt amendment
NEW YORK, Aug 9 (Reuters) - Valeant Pharmaceuticals
International's loans traded up Tuesday after the
company's chief executive officer said it would seek to modify
covenants on its $31 billion of...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment